nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Alfentanil—ABCB1—peripheral nervous system neoplasm	0.00332	0.732	CrCbGaD
Remifentanil—Fentanyl—ABCB1—peripheral nervous system neoplasm	0.00121	0.268	CrCbGaD
Remifentanil—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Remifentanil—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Remifentanil—Pruritus—Melphalan—peripheral nervous system neoplasm	0.001	0.00101	CcSEcCtD
Remifentanil—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000992	0.000996	CcSEcCtD
Remifentanil—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000986	0.00099	CcSEcCtD
Remifentanil—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000984	0.000988	CcSEcCtD
Remifentanil—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000984	0.000988	CcSEcCtD
Remifentanil—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000981	0.000986	CcSEcCtD
Remifentanil—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000978	0.000983	CcSEcCtD
Remifentanil—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000971	0.000976	CcSEcCtD
Remifentanil—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000971	0.000975	CcSEcCtD
Remifentanil—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000969	0.000973	CcSEcCtD
Remifentanil—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000968	0.000973	CcSEcCtD
Remifentanil—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000965	0.00097	CcSEcCtD
Remifentanil—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000963	0.000968	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000962	0.000966	CcSEcCtD
Remifentanil—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000959	0.000964	CcSEcCtD
Remifentanil—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000958	0.000963	CcSEcCtD
Remifentanil—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000951	0.000955	CcSEcCtD
Remifentanil—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000951	0.000955	CcSEcCtD
Remifentanil—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000943	0.000947	CcSEcCtD
Remifentanil—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000943	0.000947	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000941	0.000945	CcSEcCtD
Remifentanil—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000932	0.000936	CcSEcCtD
Remifentanil—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000932	0.000936	CcSEcCtD
Remifentanil—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000929	0.000933	CcSEcCtD
Remifentanil—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000928	0.000933	CcSEcCtD
Remifentanil—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000928	0.000933	CcSEcCtD
Remifentanil—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000922	0.000927	CcSEcCtD
Remifentanil—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000922	0.000926	CcSEcCtD
Remifentanil—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000916	0.00092	CcSEcCtD
Remifentanil—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000914	0.000918	CcSEcCtD
Remifentanil—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000914	0.000918	CcSEcCtD
Remifentanil—Rash—Topotecan—peripheral nervous system neoplasm	0.000914	0.000918	CcSEcCtD
Remifentanil—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000913	0.000917	CcSEcCtD
Remifentanil—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000911	0.000915	CcSEcCtD
Remifentanil—Cough—Etoposide—peripheral nervous system neoplasm	0.000909	0.000914	CcSEcCtD
Remifentanil—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000909	0.000913	CcSEcCtD
Remifentanil—Headache—Topotecan—peripheral nervous system neoplasm	0.000908	0.000912	CcSEcCtD
Remifentanil—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000907	0.000911	CcSEcCtD
Remifentanil—Rash—Tretinoin—peripheral nervous system neoplasm	0.000907	0.000911	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000907	0.000911	CcSEcCtD
Remifentanil—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000906	0.00091	CcSEcCtD
Remifentanil—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000906	0.00091	CcSEcCtD
Remifentanil—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000906	0.00091	CcSEcCtD
Remifentanil—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000903	0.000907	CcSEcCtD
Remifentanil—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000902	0.000906	CcSEcCtD
Remifentanil—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000902	0.000906	CcSEcCtD
Remifentanil—Headache—Tretinoin—peripheral nervous system neoplasm	0.000901	0.000905	CcSEcCtD
Remifentanil—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000901	0.000905	CcSEcCtD
Remifentanil—Hypertension—Etoposide—peripheral nervous system neoplasm	0.0009	0.000904	CcSEcCtD
Remifentanil—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000898	0.000902	CcSEcCtD
Remifentanil—Constipation—Vincristine—peripheral nervous system neoplasm	0.000898	0.000902	CcSEcCtD
Remifentanil—Pain—Vincristine—peripheral nervous system neoplasm	0.000898	0.000902	CcSEcCtD
Remifentanil—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000898	0.000902	CcSEcCtD
Remifentanil—Rash—Melphalan—peripheral nervous system neoplasm	0.000895	0.000899	CcSEcCtD
Remifentanil—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000894	0.000898	CcSEcCtD
Remifentanil—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000883	0.000887	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000881	0.000885	CcSEcCtD
Remifentanil—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000868	0.000872	CcSEcCtD
Remifentanil—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000867	0.000871	CcSEcCtD
Remifentanil—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000866	0.00087	CcSEcCtD
Remifentanil—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000866	0.00087	CcSEcCtD
Remifentanil—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000861	0.000865	CcSEcCtD
Remifentanil—Nausea—Topotecan—peripheral nervous system neoplasm	0.000861	0.000865	CcSEcCtD
Remifentanil—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000858	0.000862	CcSEcCtD
Remifentanil—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000854	0.000858	CcSEcCtD
Remifentanil—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000854	0.000858	CcSEcCtD
Remifentanil—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000854	0.000857	CcSEcCtD
Remifentanil—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000851	0.000854	CcSEcCtD
Remifentanil—Nausea—Melphalan—peripheral nervous system neoplasm	0.000843	0.000847	CcSEcCtD
Remifentanil—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000838	0.000842	CcSEcCtD
Remifentanil—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000834	0.000838	CcSEcCtD
Remifentanil—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000833	0.000837	CcSEcCtD
Remifentanil—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00083	0.000834	CcSEcCtD
Remifentanil—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00083	0.000834	CcSEcCtD
Remifentanil—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000828	0.000832	CcSEcCtD
Remifentanil—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000826	0.00083	CcSEcCtD
Remifentanil—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000822	0.000826	CcSEcCtD
Remifentanil—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000817	0.000821	CcSEcCtD
Remifentanil—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000806	0.00081	CcSEcCtD
Remifentanil—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000804	0.000808	CcSEcCtD
Remifentanil—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000803	0.000806	CcSEcCtD
Remifentanil—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000803	0.000806	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000802	0.000805	CcSEcCtD
Remifentanil—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000795	0.000798	CcSEcCtD
Remifentanil—Pain—Cisplatin—peripheral nervous system neoplasm	0.000794	0.000798	CcSEcCtD
Remifentanil—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000784	0.000788	CcSEcCtD
Remifentanil—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000776	0.000779	CcSEcCtD
Remifentanil—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000774	0.000777	CcSEcCtD
Remifentanil—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000771	0.000774	CcSEcCtD
Remifentanil—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000765	0.000769	CcSEcCtD
Remifentanil—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000764	0.000767	CcSEcCtD
Remifentanil—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000758	0.000762	CcSEcCtD
Remifentanil—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000756	0.00076	CcSEcCtD
Remifentanil—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000756	0.00076	CcSEcCtD
Remifentanil—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000752	0.000755	CcSEcCtD
Remifentanil—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000747	0.000751	CcSEcCtD
Remifentanil—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000746	0.000749	CcSEcCtD
Remifentanil—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000746	0.000749	CcSEcCtD
Remifentanil—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000741	0.000744	CcSEcCtD
Remifentanil—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000735	0.000738	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000734	0.000738	CcSEcCtD
Remifentanil—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000734	0.000737	CcSEcCtD
Remifentanil—Constipation—Etoposide—peripheral nervous system neoplasm	0.000727	0.000731	CcSEcCtD
Remifentanil—Pain—Etoposide—peripheral nervous system neoplasm	0.000727	0.000731	CcSEcCtD
Remifentanil—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000725	0.000729	CcSEcCtD
Remifentanil—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000721	0.000724	CcSEcCtD
Remifentanil—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000718	0.000722	CcSEcCtD
Remifentanil—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000717	0.00072	CcSEcCtD
Remifentanil—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000713	0.000716	CcSEcCtD
Remifentanil—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000701	0.000704	CcSEcCtD
Remifentanil—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.0007	0.000703	CcSEcCtD
Remifentanil—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000698	0.000701	CcSEcCtD
Remifentanil—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000696	0.000699	CcSEcCtD
Remifentanil—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000694	0.000698	CcSEcCtD
Remifentanil—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000693	0.000696	CcSEcCtD
Remifentanil—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000687	0.00069	CcSEcCtD
Remifentanil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000686	0.00069	CcSEcCtD
Remifentanil—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000684	0.000687	CcSEcCtD
Remifentanil—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000683	0.000686	CcSEcCtD
Remifentanil—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000683	0.000686	CcSEcCtD
Remifentanil—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.00068	0.000683	CcSEcCtD
Remifentanil—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000676	0.000679	CcSEcCtD
Remifentanil—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000675	0.000678	CcSEcCtD
Remifentanil—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000672	0.000675	CcSEcCtD
Remifentanil—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000671	0.000674	CcSEcCtD
Remifentanil—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000668	0.000671	CcSEcCtD
Remifentanil—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000666	0.000669	CcSEcCtD
Remifentanil—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000663	0.000666	CcSEcCtD
Remifentanil—Rash—Vincristine—peripheral nervous system neoplasm	0.000662	0.000665	CcSEcCtD
Remifentanil—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000661	0.000664	CcSEcCtD
Remifentanil—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.00066	0.000663	CcSEcCtD
Remifentanil—Headache—Vincristine—peripheral nervous system neoplasm	0.000658	0.000661	CcSEcCtD
Remifentanil—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000647	0.00065	CcSEcCtD
Remifentanil—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000647	0.00065	CcSEcCtD
Remifentanil—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000635	0.000638	CcSEcCtD
Remifentanil—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000632	0.000635	CcSEcCtD
Remifentanil—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000627	0.00063	CcSEcCtD
Remifentanil—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000624	0.000627	CcSEcCtD
Remifentanil—Nausea—Vincristine—peripheral nervous system neoplasm	0.000624	0.000627	CcSEcCtD
Remifentanil—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000623	0.000626	CcSEcCtD
Remifentanil—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000623	0.000626	CcSEcCtD
Remifentanil—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000621	0.000624	CcSEcCtD
Remifentanil—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000616	0.000619	CcSEcCtD
Remifentanil—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000609	0.000612	CcSEcCtD
Remifentanil—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000606	0.000609	CcSEcCtD
Remifentanil—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000605	0.000608	CcSEcCtD
Remifentanil—Chills—Epirubicin—peripheral nervous system neoplasm	0.000602	0.000605	CcSEcCtD
Remifentanil—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000602	0.000605	CcSEcCtD
Remifentanil—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.0006	0.000602	CcSEcCtD
Remifentanil—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000598	0.000601	CcSEcCtD
Remifentanil—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00059	0.000593	CcSEcCtD
Remifentanil—Rash—Cisplatin—peripheral nervous system neoplasm	0.000585	0.000588	CcSEcCtD
Remifentanil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000585	0.000588	CcSEcCtD
Remifentanil—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000584	0.000587	CcSEcCtD
Remifentanil—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000582	0.000585	CcSEcCtD
Remifentanil—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000576	0.000579	CcSEcCtD
Remifentanil—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000576	0.000579	CcSEcCtD
Remifentanil—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.000566	CcSEcCtD
Remifentanil—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000562	0.000565	CcSEcCtD
Remifentanil—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000561	0.000563	CcSEcCtD
Remifentanil—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00056	0.000562	CcSEcCtD
Remifentanil—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000557	0.00056	CcSEcCtD
Remifentanil—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000555	0.000557	CcSEcCtD
Remifentanil—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000551	0.000554	CcSEcCtD
Remifentanil—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000541	0.000543	CcSEcCtD
Remifentanil—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000541	0.000543	CcSEcCtD
Remifentanil—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.00054	0.000542	CcSEcCtD
Remifentanil—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000537	0.000539	CcSEcCtD
Remifentanil—Rash—Etoposide—peripheral nervous system neoplasm	0.000536	0.000539	CcSEcCtD
Remifentanil—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000536	0.000538	CcSEcCtD
Remifentanil—Headache—Etoposide—peripheral nervous system neoplasm	0.000533	0.000535	CcSEcCtD
Remifentanil—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000526	CcSEcCtD
Remifentanil—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000513	0.000516	CcSEcCtD
Remifentanil—Cough—Epirubicin—peripheral nervous system neoplasm	0.00051	0.000512	CcSEcCtD
Remifentanil—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000506	0.000508	CcSEcCtD
Remifentanil—Nausea—Etoposide—peripheral nervous system neoplasm	0.000505	0.000508	CcSEcCtD
Remifentanil—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000504	0.000507	CcSEcCtD
Remifentanil—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.0005	0.000502	CcSEcCtD
Remifentanil—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000497	0.000499	CcSEcCtD
Remifentanil—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000496	0.000498	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000494	0.000496	CcSEcCtD
Remifentanil—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000486	0.000489	CcSEcCtD
Remifentanil—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000487	CcSEcCtD
Remifentanil—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000483	CcSEcCtD
Remifentanil—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000477	0.000479	CcSEcCtD
Remifentanil—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000477	0.000479	CcSEcCtD
Remifentanil—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000475	0.000477	CcSEcCtD
Remifentanil—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000472	0.000474	CcSEcCtD
Remifentanil—Shock—Epirubicin—peripheral nervous system neoplasm	0.000469	0.000471	CcSEcCtD
Remifentanil—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.00047	CcSEcCtD
Remifentanil—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000468	0.00047	CcSEcCtD
Remifentanil—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000467	0.000469	CcSEcCtD
Remifentanil—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.000469	CcSEcCtD
Remifentanil—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000465	0.000467	CcSEcCtD
Remifentanil—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000463	0.000465	CcSEcCtD
Remifentanil—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000461	0.000463	CcSEcCtD
Remifentanil—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000459	0.000461	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000457	0.000459	CcSEcCtD
Remifentanil—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00045	0.000452	CcSEcCtD
Remifentanil—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000446	0.000448	CcSEcCtD
Remifentanil—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000447	CcSEcCtD
Remifentanil—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000443	CcSEcCtD
Remifentanil—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000443	CcSEcCtD
Remifentanil—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000434	0.000436	CcSEcCtD
Remifentanil—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000433	0.000435	CcSEcCtD
Remifentanil—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.000434	CcSEcCtD
Remifentanil—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000433	CcSEcCtD
Remifentanil—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000429	0.00043	CcSEcCtD
Remifentanil—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000428	0.00043	CcSEcCtD
Remifentanil—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000426	0.000428	CcSEcCtD
Remifentanil—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000425	0.000427	CcSEcCtD
Remifentanil—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000424	0.000426	CcSEcCtD
Remifentanil—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00042	0.000422	CcSEcCtD
Remifentanil—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000414	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000412	0.000414	CcSEcCtD
Remifentanil—Pain—Epirubicin—peripheral nervous system neoplasm	0.000408	0.00041	CcSEcCtD
Remifentanil—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000408	0.00041	CcSEcCtD
Remifentanil—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000396	0.000398	CcSEcCtD
Remifentanil—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000395	CcSEcCtD
Remifentanil—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000395	CcSEcCtD
Remifentanil—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000392	0.000394	CcSEcCtD
Remifentanil—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000388	0.00039	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.000383	CcSEcCtD
Remifentanil—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000381	CcSEcCtD
Remifentanil—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000379	CcSEcCtD
Remifentanil—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000379	CcSEcCtD
Remifentanil—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000379	CcSEcCtD
Remifentanil—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000365	CcSEcCtD
Remifentanil—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000353	CcSEcCtD
Remifentanil—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000352	CcSEcCtD
Remifentanil—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.00035	CcSEcCtD
Remifentanil—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000337	0.000339	CcSEcCtD
Remifentanil—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000328	CcSEcCtD
Remifentanil—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000327	CcSEcCtD
Remifentanil—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000317	CcSEcCtD
Remifentanil—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.000314	CcSEcCtD
Remifentanil—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000305	CcSEcCtD
Remifentanil—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000303	CcSEcCtD
Remifentanil—Rash—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000302	CcSEcCtD
Remifentanil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000302	CcSEcCtD
Remifentanil—Headache—Epirubicin—peripheral nervous system neoplasm	0.000299	0.0003	CcSEcCtD
Remifentanil—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000293	CcSEcCtD
Remifentanil—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000285	CcSEcCtD
Remifentanil—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000282	CcSEcCtD
Remifentanil—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000279	CcSEcCtD
Remifentanil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000279	CcSEcCtD
Remifentanil—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000278	CcSEcCtD
Remifentanil—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000263	CcSEcCtD
